Evidence map›Paper›PMID 33850144›Full record

ArticleNature communications2021

Direct 1,3-butadiene biosynthesis in Escherichia coli via a tailored ferulic acid decarboxylase mutant.

Yutaro Mori, Shuhei Noda, Tomokazu Shirai, Akihiko Kondo

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 50 citations in OpenAlex.

  1. Balancing Dimerization and Hydrogenation Kinetics by Stabilizing CuAngewandte Chemie (International ed. in English) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Styrene Production in Genetically EngineeredBiotech (Basel (Switzerland)) · 2024
    Article
  7. Microbial production ofSynthetic and systems biotechnology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yutaro MoriCenter for Sustainable Resource Science, RIKEN, Yokohama, Japan.
Shuhei NodaCenter for Sustainable Resource Science, RIKEN, Yokohama, Japan.
Tomokazu ShiraiCenter for Sustainable Resource Science, RIKEN, Yokohama, Japan. tomokazu.shirai@riken.jp.ORCID 0000-0002-8565-5895
Akihiko KondoCenter for Sustainable Resource Science, RIKEN, Yokohama, Japan.
RIKEN Center for Sustainable Resource Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The C4 unsaturated compound 1,3-butadiene is an important monomer in synthetic rubber and engineering plastic production. However, microorganisms cannot directly produce 1,3-butadiene when glucose is used as a renewable carbon source via biological processes. In this study, we construct an artificial metabolic pathway for 1,3-butadiene production from glucose in Escherichia coli by combining the cis,cis-muconic acid (ccMA)-producing pathway together with tailored ferulic acid decarboxylase mutations. The rational design of the substrate-binding site of the enzyme by computational simulations improves ccMA decarboxylation and thus 1,3-butadiene production. We find that changing dissolved oxygen (DO) levels and controlling the pH are important factors for 1,3-butadiene production. Using DO-stat fed-batch fermentation, we produce 2.13 ± 0.17 g L

Indexed as

Batch Cell Culture TechniquesButadienesCarboxy-LyasesEscherichia coliFermentationGlucoseMetabolic EngineeringMetabolic Networks and PathwaysMolecular Docking Simulation1,3-butadieneButadienesCarboxy-LyasesGlucosephenylacrylic acid decarboxylase

Identifiers

PMID33850144
PMCPMC8044207
OpenAlexW3136660322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.